Descrição do produto
Antineoplásico Injeção de doxorrubicina 10ml: 20mg can be used as First-line of systemic chemotherapy drugs or as second-line chemotherapy drugs for treatment with progression of AIDS-KS patients, also can be used to can’t tolerate the following more than two drug combination chemotherapy patients: vincristine, bleomycin and doxorubicin. Injeção antineoplásica de doxorrubicina can be used for low CD4 (3) and has a broad visceral disease of skin mucosa viscera and related to HIV/AIDS AIDS – KS patients.
Nome do medicamento
Nome genérico. Injeção de lipossoma de cloridrato de doxorrubicina
Nome inglês. Injeção de lipossoma de cloridrato de doxorrubicina
Molecular Formular. C27H29NO11 HCl
Peso molecular. 579,99
Injeção antineoplásica de doxorrubicina Descrição
This product is red semitransparent mixed suspension.
Injeção antineoplásica de doxorrubicina Indicações
1. This product can be used for low CD4 (3) and has a broad visceral disease of skin mucosa viscera and related to HIV/AIDS AIDS – KS patients.
2. This product can be used as First-line of systemic chemotherapy drugs or as second-line chemotherapy drugs for treatment with progression of AIDS-KS patients, also can be used to can’t tolerate the following more than two drug combination chemotherapy patients:vincristine, bleomycin and doxorubicin (or other anthracycline Antibióticos).
Especificação
20mg/ 10ml
Embalagem
1 garrafa/caixa
Preparativos
injeção
